SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Helwig Steven

(Last)

(First)

(Middle)

C/O RADIUS HEALTH, INC.

22 BOSTON WHARF ROAD, 7TH FLOOR

(Street)

BOSTON

02210

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/24/2021

3. Issuer Name and Ticker or Trading Symbol
Radius Health, Inc. [ RDUS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Principal Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	15,704⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	08/26/2025	Common Stock	10,750	$63.34	D
Stock Option (Right to Buy)	⁽³⁾	02/22/2029	Common Stock	3,500	$19.18	D
Stock Option (Right to Buy)	⁽⁴⁾	03/02/2030	Common Stock	3,500	$20.25	D
Stock Option (Right to Buy)	⁽⁵⁾	01/20/2031	Common Stock	12,250	$21.66	D
Stock Option (Right to Buy)	⁽⁶⁾	02/22/2031	Common Stock	20,000	$18.6	D

Explanation of Responses:

1. The amount reflected includes 375 restricted stock units awarded under the 2011 Equity Incentive Plan and 4,542 restricted stock units awarded under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The shares underlying the restricted stock units vest as follows: (a) 375 of such shares shall vest on February 13, 2022; (b) 1,000 of such shares shall vest as to 50% on February 22, 2022 and 50% on February 22, 2023; (c) 1,667 of such shares shall vest as to 50% on March 2, 2022 and 50% on March 2, 2023; and (d) 1,875 of such shares shall vest as to 33.33% on November 9, 2021 and as to 33.33% annually thereafter over the following two years on November 9 of each year.

2. The shares subject to this stock option are fully vested and exercisable.

3. 25% of the shares subject to this stock option vested on February 22, 2020; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.

4. 25% of the shares are subject to this stock option vested on March 2, 2021; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.

5. 25% of the shares subject to this stock option shall vest on January 20, 2022; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.

6. 25% of the shares subject to this stock option shall vest on February 22, 2022; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.

Remarks:

	/s/ Averi Price, as attorney-in-fact	08/26/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.